Table of Contents
Journal of Signal Transduction
Volume 2013 (2013), Article ID 239320, 12 pages
http://dx.doi.org/10.1155/2013/239320
Research Article

An Fc Gamma Receptor-Mediated Upregulation of the Production of Interleukin 10 by Intravenous Immunoglobulin in Bone-Marrow-Derived Mouse Dendritic Cells Stimulated with Lipopolysaccharide In Vitro

Japan Blood Products Organization, Central Research Laboratory, Protein Pharmacology Research Section, 1-5-2 Minatojima Minami-machi, Chuo-ku, Kobe, Hyogo 650-0047, Japan

Received 20 March 2013; Revised 24 May 2013; Accepted 2 June 2013

Academic Editor: Rudi Beyaert

Copyright © 2013 Akihiro Fujii et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Young and R. M. Steinman, “The hematopoietic development of dendritic cellsa distinct pathway for myeloid differentiation,” Stem Cells, vol. 14, no. 4, pp. 376–387, 1996. View at Google Scholar · View at Scopus
  2. J. Banchereau and R. M. Steinman, “Dendritic cells and the control of immunity,” Nature, vol. 392, no. 6673, pp. 245–252, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. H.-R. Jiang, E. Muckersie, M. Robertson, H. Xu, J. Liversidge, and J. V. Forrester, “Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture,” Journal of Leukocyte Biology, vol. 72, no. 5, pp. 978–985, 2002. View at Google Scholar · View at Scopus
  4. G. Trinchieri, “Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity,” Annual Review of Immunology, vol. 13, pp. 251–276, 1995. View at Google Scholar · View at Scopus
  5. C.-Q. Xia and K. J. Kao, “Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells: involvement of activation of extracellular signal-regulated protein kinase,” Scandinavian Journal of Immunology, vol. 58, no. 1, pp. 23–32, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. R. de Waal Malefyt, J. Haanen, H. Spits et al., “Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression,” Journal of Experimental Medicine, vol. 174, no. 4, pp. 915–924, 1991. View at Google Scholar · View at Scopus
  7. K. Steinbrink, M. Wölfl, H. Jonuleit, J. Knop, and A. H. Enk, “Induction of tolerance by IL-10-treated dendritic cells,” Journal of Immunology, vol. 159, no. 10, pp. 4772–4780, 1997. View at Google Scholar · View at Scopus
  8. M. D. Kazatchkine and S. V. Kaveri, “Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin,” The New England Journal of Medicine, vol. 345, no. 10, pp. 747–755, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. V. S. Negi, S. Elluru, S. Sibéril et al., “Intravenous immunoglobulin: an update on the clinical use and mechanisms of action,” Journal of Clinical Immunology, vol. 27, no. 3, pp. 233–245, 2007. View at Google Scholar
  10. M. Ballow and C. Allen, “Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes,” Clinical Immunology, vol. 139, no. 2, pp. 208–214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Kwekkeboom, “Modulation of dendritic cells and regulatory T cells by naturally occurring antibodies,” Advances in Experimental Medicine and Biology, vol. 750, chapter 10, pp. 133–144, 2012. View at Google Scholar
  12. J. Bayry, S. Lacroix-Desmazes, C. Carbonneil et al., “Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin,” Blood, vol. 101, no. 2, pp. 758–765, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Guha and N. Mackman, “LPS induction of gene expression in human monocytes,” Cellular Signalling, vol. 13, no. 2, pp. 85–94, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. B. M. Neves, M. T. Cruz, V. Francisco et al., “Differential roles of PI3-Kinase, MAPKs and NF-κB on the manipulation of dendritic cell Th1/Th2 cytokine/chemokine polarizing profile,” Molecular Immunology, vol. 46, no. 13, pp. 2481–2492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J.-F. Arrighi, M. Rebsamen, F. Rousset, V. Kindler, and C. Hauser, “A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers,” Journal of Immunology, vol. 166, no. 6, pp. 3837–3845, 2001. View at Google Scholar · View at Scopus
  16. S. von Gunten, D. F. Smith, R. D. Cummings et al., “Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass,” Journal of Allergy and Clinical Immunology, vol. 123, no. 6, pp. 1268–1276, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Yada, S. Ebihara, K. Matsumura et al., “Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/RIII-mediated immune complex uptake,” Cellular Immunology, vol. 225, no. 1, pp. 21–32, 2003. View at Google Scholar
  18. J. V. Ravetch and S. Bolland, “IgG Fc receptors,” Annual Review of Immunology, vol. 19, pp. 275–290, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Sedlik, D. Orbach, P. Veron et al., “A critical role for Syk protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation,” Journal of Immunology, vol. 170, no. 2, pp. 846–852, 2003. View at Google Scholar · View at Scopus
  20. J. M. Oliver, D. L. Burg, B. S. Wilson, J. L. McLaughlin, and R. L. Geahlen, “Inhibition of mast cell FcεR1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol,” Journal of Biological Chemistry, vol. 269, no. 47, pp. 29697–29703, 1994. View at Google Scholar · View at Scopus
  21. J. H. Hanke, J. P. Gardner, R. L. Dow et al., “Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor,” Journal of Biological Chemistry, vol. 271, no. 2, pp. 695–701, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Sobota, A. Strzelecka-Kiliszek, E. Gladkowska, K. Yoshida, K. Mrozińska, and K. Kwiatkowska, “Binding of IgG-opsonized particles to FcγR is an active stage of phagocytosis that involves receptor clustering and phosphorylation,” Journal of Immunology, vol. 175, no. 7, pp. 4450–4457, 2005. View at Google Scholar · View at Scopus
  23. M. B. Lutz, N. Kukutsch, A. L. J. Ogilvie et al., “An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow,” Journal of Immunological Methods, vol. 223, no. 1, pp. 77–92, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Murakami, C. Suzuki, F. Kobayashi et al., “Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways,” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 385, no. 9, pp. 891–898, 2012. View at Google Scholar
  25. T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the comparative CT method,” Nature Protocols, vol. 3, no. 6, pp. 1101–1108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. M. Mäkelä, M. Strengell, T. E. Pietilä, P. Österlund, and I. Julkunen, “Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells,” Journal of Leukocyte Biology, vol. 85, no. 4, pp. 664–672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Nakahara, H. Uchi, K. Urabe, Q. Chen, M. Furue, and Y. Moroi, “Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells,” International Immunology, vol. 16, no. 12, pp. 1701–1709, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A.-K. Yi, J.-G. Yoon, S.-J. Yeo, S.-C. Hong, B. K. English, and A. M. Krieg, “Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response,” Journal of Immunology, vol. 168, no. 9, pp. 4711–4720, 2002. View at Google Scholar · View at Scopus
  29. C. Qian, X. Jiang, H. An et al., “TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation,” Blood, vol. 108, no. 7, pp. 2307–2315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Yanagawa and K. Onoé, “Enhanced IL-10 production by TLR4- and TLR2-primed dendritic cells upon TLR restimulation,” Journal of Immunology, vol. 178, no. 10, pp. 6173–6180, 2007. View at Google Scholar · View at Scopus
  31. O. Letourneur, I. C. S. Kennedy, A. T. Brini, J. R. Ortaldo, J. J. O'Shea, and J.-P. Kinet, “Characterization of the family of dimers associated with Fc receptors (FcεRI and FcγRIII),” Journal of Immunology, vol. 147, no. 8, pp. 2652–2656, 1991. View at Google Scholar · View at Scopus
  32. P. R. Scholl and R. S. Geha, “Physical association between the high-affinity IgG receptor (FcγRI) and the γ subunit of the high-affinity IgE receptor (FcεRIγ),” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 19, pp. 8847–8850, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. A. V. T. Wang, P. R. Scholl, and R. S. Geha, “Physical and functional association of the high affinity immunoglobulin G receptor (FcγRI) with the kinases Hck and Lyn,” Journal of Experimental Medicine, vol. 180, no. 3, pp. 1165–1170, 1994. View at Publisher · View at Google Scholar · View at Scopus
  34. D. L. Durden and Y. B. L. Yen bou Liu, “Protein-tyrosine kinase p72(syk) in FcγRI receptor signaling,” Blood, vol. 84, no. 7, pp. 2102–2108, 1994. View at Google Scholar · View at Scopus
  35. H. F. MacMillan, T. Lee, and A. C. Issekutz, “Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation,” Clinical Immunology, vol. 132, no. 2, pp. 222–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. S. Maddur, M. Sharma, P. Hegde, S. Lacroix-Desmazes, S. V. Kaveri, and J. Bayry, “Inhibitory effects of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations,” Journal of Clinical Immunology, vol. 33, supplement 1, pp. S62–S66, 2013. View at Google Scholar
  37. J.-F. Séité, T. Guerrier, D. Cornec, C. Jamin, P. Youinou, and S. Hillion, “TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase,” Journal of Autoimmunity, vol. 37, no. 3, pp. 190–197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. L. K. Ernst, A.-M. Duchemin, and C. L. Anderson, “Association of the high-affinity receptor for IgG (FcγRI) with the γ subunit of the IgE receptor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 13, pp. 6023–6027, 1993. View at Google Scholar · View at Scopus
  39. R. O. de Castro, “Regulation and function of Syk tyrosine kinase in mast cell signaling and beyond,” Journal of Signal Transduction, vol. 2011, Article ID 507291, 9 pages, 2011. View at Publisher · View at Google Scholar
  40. C. Darby, R. L. Geahlen, and A. D. Schreiber, “Stimulation of macrophage FcγRIIIA activates the receptor-associated protein tyrosine kinase Syk and induces phosphorylation of multiple proteins including p95Vav and p62/GAP-associated protein,” Journal of Immunology, vol. 152, no. 11, pp. 5429–5437, 1994. View at Google Scholar · View at Scopus
  41. Z. K. Indik, J.-G. Park, S. Hunter, and A. D. Schreiber, “The molecular dissection of Fcγ receptor mediated phagocytosis,” Blood, vol. 86, no. 12, pp. 4389–4399, 1995. View at Google Scholar · View at Scopus
  42. A. Strzelecka, K. Kwiatkowska, and A. Sobota, “Tyrosine phosphorylation and Fcγ receptor-mediated phagocytosis,” FEBS Letters, vol. 400, no. 1, pp. 11–14, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Cox and S. Greenberg, “Phagocytic signaling strategies: Fcγ receptor-mediated phagocytosis as a model system,” Seminars in Immunology, vol. 13, no. 6, pp. 339–345, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. R. J. Lories, M. Casteels-Van Daele, J. L. Ceuppens, and S. W. Van Gool, “Polyclonal immunoglobulins for intravenous use induce interleukin 10 release in vivo and in vitro,” Annals of the Rheumatic Diseases, vol. 63, no. 6, pp. 747–748, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. R. P. Donnelly, H. Dickensheets, and D. S. Finbloom, “The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes,” Journal of Interferon and Cytokine Research, vol. 19, no. 6, pp. 563–573, 1999. View at Publisher · View at Google Scholar · View at Scopus